Publication date: Jul 01, 2024
Recent studies elucidate that coronavirus disease 2019 (COVID-19) patients may face a higher risk of cardiovascular complications. This study aimed to evaluate association of COVID-19 with the risk of pulmonary embolism (PE) or deep vein thrombosis (DVT). This nationwide population-based retrospective cohort study included Korean adult citizens between January 2021 and March 2022 from the Korea Disease Control and Prevention Agency COVID-19 National Health Insurance Service cohort. The Fine and Gray’s regression with all-cause death as a competing event was adopted to evaluate PE and DVT risks after COVID-19. This study included a total of 1,601,835 COVID-19 patients and 14,011,285 matched individuals without COVID-19. The risk of PE (adjusted hazard ratio [aHR], 6. 25; 95% confidence interval [CI], 3. 67-10. 66; p
| Concepts | Keywords |
|---|---|
| Coronavirus | embolism |
| Death | long‐term sequelae |
| Korean | postacute COVID‐19 syndrome |
| SARS‐CoV‐2 | |
| thrombosis |
Semantics
| Type | Source | Name |
|---|---|---|
| disease | MESH | pulmonary embolism |
| disease | MESH | deep vein thrombosis |
| disease | MESH | COVID-19 |
| disease | MESH | complications |
| disease | VO | population |
| disease | MESH | death |
| disease | MESH | Long Covid |
| disease | MESH | embolism |
| disease | MESH | syndrome |
| disease | MESH | thrombosis |